Michael Hearne
2020
In 2020, Michael Hearne earned a total compensation of $572.2K as Chief Financial Officer at Odonate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $51,400 |
|---|---|
| Option Awards | $320,945 |
| Salary | $191,781 |
| Other | $8,045 |
| Total | $572,172 |
Hearne received $320.9K in option awards, accounting for 56% of the total pay in 2020.
Hearne also received $51.4K in non-equity incentive plan, $191.8K in salary and $8K in other compensation.
Rankings
In 2020, Michael Hearne's compensation ranked 10,638th out of 13,090 executives tracked by ExecPay. In other words, Hearne earned more than 18.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,638 out of 13,090 | 19th |
Division Manufacturing | 4,557 out of 5,624 | 19th |
Major group Chemicals And Allied Products | 1,893 out of 2,257 | 16th |
Industry group Drugs | 1,659 out of 1,957 | 15th |
Industry Pharmaceutical Preparations | 1,226 out of 1,462 | 16th |
Source: SEC filing on June 1, 2021.
Hearne's colleagues
We found two more compensation records of executives who worked with Michael Hearne at Odonate Therapeutics in 2020.